Table 3.

KEGG enrichment summary

GEO accession	ID	Description	p.adjust	qvalue	Count
GSE13355	hsa04061	Viral protein interaction with cytokine and cytokine receptor	1.13E-09	9.21E-10	10
	hsa04060	Cytokine-cytokine receptor interaction	1.88E-06	1.53E-06	11
	hsa04062	Chemokine signaling pathway	3.62E-06	2.94E-06	9
	hsa04657	IL-17 signaling pathway	3.62E-06	2.94E-06	7
	hsa05164	Influenza A	0.001870867	0.001518523	6
	hsa04622	RIG-I-like receptor signaling pathway	0.003759724	0.003051647	4
	hsa05160	Hepatitis C	0.008015124	0.006505618	5
	hsa05146	Amoebiasis	0.011253432	0.009134047	4
	hsa04620	Toll-like receptor signaling pathway	0.011253432	0.009134047	4
	hsa05171	Coronavirus disease—COVID-19	0.029315198	0.0237942	5
	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	0.029315198	0.0237942	3
GSE30999	hsa04061	Viral protein interaction with cytokine and cytokine receptor	0.000671079	0.000591225	5
	hsa05323	Rheumatoid arthritis	0.003891546	0.003428479	4
	hsa04657	IL-17 signaling pathway	0.003891546	0.003428479	4
	hsa04060	Cytokine-cytokine receptor interaction	0.027838544	0.024525948	5
	hsa04062	Chemokine signaling pathway	0.034931897	0.030775241	4
	hsa05146	Amoebiasis	0.039637888	0.034921252	3
	hsa04064	NF-kappa B signaling pathway	0.039637888	0.034921252	3